Takeda has been given a $38 million grant from the Bill & Melinda Gates Foundation to support global polio eradication in developing countries as the world is on the brink of ending the spread of the disease forever.
With this funding, the Japanese drugmaker said it will develop, license and supply at least 50 million doses per year of Sabin-strain inactivated poliovirus vaccine (sIPV) to more than 70 developing countries. The vaccine will be manufactured at Takeda’s facility in Hikari, Japan.
As part of a global plan to eradicate the crippling disease--which experts say the world could see the last case this year--countries will need to switch from using oral polio vaccine to the inactivated polio vaccine to make sure the disease does not reappear.
Read more here